Track the 압타바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 압타바이오 has recorded 19 reports. The latest transaction was disclosed on 28 May 2025 (Sale). Among the most active insiders: 이수진. Every trade is accessible without an account.
19
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.